Danone said on Thursday that China will remain a key growth driver for the world's largest yoghurt maker, as medical nutrition and beverages categories remain robust, Reuters reported.
Danone price negotiations hit obstacles in Europe as market share lost
Danone logo. Credit: ricochet64 / Shutterstock

Medical nutrition, beverage categories remain robust.

Danone said on Thursday that China will remain a key growth driver for the world’s largest yoghurt maker, as medical nutrition and beverages categories remain robust, Reuters reported.

In 2022, demand for Danone’s Chinese vitamin drink brand Mizone was hit by the country’s no-COVID policy, but the company turned this around in 2023, making China its “number one driver”, Chief Financial Officer Juergen Esser said.

“We’re going to continue growing fast in China,” Esser told Reuters in an interview.

China’s aging population generates high interest in Danone’s medical nutrition business, which drives growth along with the beverages category, Esser said.

Meanwhile, the infant nutrition business continues to be under pressure due to declining birth rates, he added.

Danone beat expectations for first quarter volume/mix on Thursday, as a 6.9% increase in China drove a 1.2% rise for the group, with the Waters segment recording double-digit percentage sales growth on a like-for-like basis.

You can now read the most important #news on #eDairyNews #Whatsapp channels!!!

🇺🇸 eDairy News INGLÊS: https://whatsapp.com/channel/0029VaKsjzGDTkJyIN6hcP1K

Look also

Bird flu was probably circulating in dairy cows for at least four months before it was confirmed to be the highly pathogenic H5N1 virus, according to a new analysis of genomic data by scientists at the US Department of Agriculture’s Animal Disease Center.

You may be interested in

Related
notes

Most Read

Featured

Join to

Follow us

SUBSCRIBE TO OUR NEWSLETTER